Hitting parasites where they hurt: New research shows promise in the fight against Toxoplasmosis

May 21, 2012 by James Hataway

Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, is one of the most common parasitic infections in the world. In the U.S. it is estimated that more than 22 percent of the population 12 years and older have been infected with toxoplasma, according to the Centers for Disease Control and Prevention.

Now, thanks in part to a five-year, $1.8-million grant from the National Institutes of Health, University of Georgia researcher Silvia Moreno has identified a potential target for new therapies against toxoplasma infection, which may help to protect people with compromised immune systems, developing and other sensitive populations from serious harm.

Toxoplasma works by invading healthy cells within the body, and once it has taken over, the cell's membranes protect the parasite from the . However, as it replicates and fills the cell, some parasites must venture out to find new cells to attack. It is during this process, when toxoplasma is outside the protective walls of the , that Moreno sees an opportunity to combat the parasite.

"We are interested in knowing how the parasite is able to survive long enough to find another host cell," said Moreno, professor of in the UGA Center for Tropical and Emerging Global Diseases and the Franklin College of Arts and Sciences.

Moreno's lab found that while toxoplasma is outside the protective host cell, it develops a large internal organelle called a vacuole that they think may protect the parasite and help it prepare to invade the next cell. Moreno and her collaborators call the organelle a "plant-like vacuole" because it bears resemblance to similar in plants.

"We think there are stresses the parasite encounters when it is outside, so it needs a mechanism to survive that shock," Moreno said. "At the same time, the parasite has to get ready to infect another cell; it needs to secrete proteins that will help it attach to the cell and invade."

For this vacuole to become a target, scientists must first understand the parasite's basic behaviors and biological functions. They can then start to create new therapies.

"We don't want to know how the parasite behaves just for the fun of it; we want to know where we can hit it," Moreno said. "That's the reason we study its biology because we want to know exactly where to hit toxoplasma with drugs."

Disrupting the function of the plant-like vacuole may render the parasite incapable of movement. If toxoplasma cannot safely leave the confines of a host cell, it cannot replicate and it cannot create a widespread infection.

Most people infected with toxoplasma are relatively safe from danger because the immune system is able to seek out and destroy the parasite before it causes harm.

"The parasite is very smart in that it does not kill healthy people," Moreno said. "If you are a parasite, you don't want to kill your host, because if you kill your host you're done too."

But toxoplasma can be incredibly dangerous to those with compromised immune systems, such as AIDS or chemotherapy patients, and to a fetus whose mother has been exposed to the parasite. In these situations, toxoplasma invades human cells and begins replicating, leaving behind cysts that damage brain and muscle tissue.

Moreno also said that toxoplasma serves as an excellent research and teaching tool because the plant-like vacuole may be present in the large and diverse group of animal called apicomplexans, which are the cause of several important infectious human diseases, including malaria. She said the lessons learned from toxoplasma could be useful in the treatment of these diseases.

Explore further: Mice infected with Toxoplasma gondii parasite show Alzheimer's improvements

Related Stories

Mice infected with Toxoplasma gondii parasite show Alzheimer's improvements

March 21, 2012
The parasite Toxoplasma gondii has some favorable effects on the pathogenesis and progression of a mouse model of Alzheimer's disease, reports a Mar. 21 study in the open access journal PLoS ONE.

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.